Filing Details
- Accession Number:
- 0001209191-11-004210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-20 16:29:51
- Reporting Period:
- 2011-01-18
- Filing Date:
- 2011-01-20
- Accepted Time:
- 2011-01-20 16:29:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1014672 | Caliper Life Sciences Inc | CALP | Laboratory Analytical Instruments (3826) | 330675808 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1254224 | E Stephen Creager | 605 Fairchild Drive Mountain View CA 94043 | Sr. Vp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-01-18 | 10,000 | $6.44 | 58,967 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 13, 2010.
- The price in Column 4 is a weighted average sale price. The prices actually received ranged from $6.35 to $6.56. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.